Related Experiment Video
Updated: Apr 14, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Inhibition of Staphylococcus aureus PriA Helicase by Flavonol Kaempferol
Yen-Hua Huang1, Chien-Chih Huang, Cheng-Chieh Chen
1School of Biomedical Sciences, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd., Taichung City, Taiwan.
Abstract:
Staphylococcus aureus is an important etiological agent responsible for healthcare-associated infections. In this study, the effect of flavonoids on the inhibition of S. aureus PriA (SaPriA), an essential helicase for DNA replication restart, which is critical for bacterial survival, was investigated. Using vanadate-sensitive colorimetric assay, the concentration of phosphate, from ATP hydrolysis by SaPriA, was decreased to 37 and 69%, respectively, in the presence of 35 μM kaempferol and myricetin. The effect of quercetin, galangin, dihydromyricetin, and myricitrin was insignificant. From titration curve, IC50 of kaempferol for SaPriA was determined to be 22 ± 2 μM. Using fluorescence quenching, we identified that kaempferol can bind to SaPriA with K(d) of 9.1 ± 3.2 μM. To our knowledge, these preliminary results constituted the first study regarding that naturally occurring product such as flavonols kaempferol and myricetin can be potent inhibitors targeting PriA.
Insights
Flavonols kaempferol and myricetin inhibit Staphylococcus aureus PriA (SaPriA), an essential enzyme for bacterial survival. This discovery offers potential new strategies for combating healthcare-associated infections caused by S. aureus.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Staphylococcus aureus is a significant cause of healthcare-associated infections.
- Bacterial helicases, like S. aureus PriA (SaPriA), are crucial for DNA replication restart and bacterial survival.
- Identifying novel inhibitors of essential bacterial enzymes is vital for developing new antimicrobial strategies.
Purpose of the Study:
- To investigate the inhibitory effects of flavonoids on Staphylococcus aureus PriA (SaPriA).
- To explore the potential of natural products as therapeutic agents against S. aureus.
Main Methods:
- Vanadate-sensitive colorimetric assay to measure ATP hydrolysis by SaPriA.
- Enzyme inhibition assays to determine IC50 values.
- Fluorescence quenching to assess the binding kinetics of flavonoids to SaPriA.
Main Results:
- Kaempferol and myricetin significantly inhibited SaPriA activity at 35 μM, reducing phosphate concentration by 37% and 69%, respectively.
- The IC50 of kaempferol for SaPriA was determined to be 22 ± 2 μM.
- Kaempferol demonstrated binding to SaPriA with a K(d) of 9.1 ± 3.2 μM.
Conclusions:
- Flavonols, specifically kaempferol and myricetin, are potent inhibitors of Staphylococcus aureus PriA.
- These findings represent the first report of natural products targeting the SaPriA helicase.
- This study highlights the potential of kaempferol and myricetin as leads for developing novel anti-staphylococcal agents.
More Related Videos
07:13Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds
Published on: August 8, 2025
11:59Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Enzyme Inhibition
Staphylococcal Skin Infections
Inhibitors of Bacterial Protein Synthesis